COMMUNIQUÉS West-GlobeNewswire

FDA Recognizes Newly Revised AAMI Sterilization, Ethylene Oxide Guidance
26/03/2025
New versions of AAMI ST58, ST24, and TIR17 included in Recognized Consensus Standards database Arlington, VA, March 26, 2025 (GLOBE NEWSWIRE) -- AAMI is pleased to announce that the FDA has amended its database of [...]
Best SARMs For Bulking, Cutting, Muscle Growth, Fat Loss Where to buy SARMs, Alternative Stack For Sale - CrazyBulk
26/03/2025
NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- SARMs for Bulking If you want to build muscle faster than usual, SARMs for bulking can help. Using a SARMs stack (a combination of supplements) gives better results than [...]
BioSig Technologies Confirms Full Compliance with Nasdaq Requirements for Continued Listing on The Nasdaq Capital Market
26/03/2025
Los Angeles, CA, March 26, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (BSGM) (“BioSig” or the “Company"), a medical technology company delivering unprecedented accuracy and precision to intra-cardiac signal [...]
Dr. Lyudmila Sarder Receives Prestigious U.S. Congressional Award for Women’s History Month
26/03/2025
"Trailblazing Physician and Advocate Receives U.S. Congressional Award for Advancing Healthcare Access and Community Service Across Central Florida and Beyond" WASHINGTON, March 26, 2025 (GLOBE NEWSWIRE) -- Dr. Lyudmila [...]
InspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare Conference
26/03/2025
MIAMI, March 26, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced [...]
Relmada Therapeutics to Report Fourth Quarter 2024 Financial Results on Thursday, March 27, 2025
26/03/2025
CORAL GABLES, Fla., March 26, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada”, or “the Company”), a clinical-stage biotechnology company committed to advancing innovative breakthrough [...]
Zelluna ASA [ZLNA]: Notification of transaction by close associate of primary insider
26/03/2025
Oslo, Norway, 26 March, 2025 Reference is made to the stock exchange notice published by Zelluna ASA (the "Company") published on 26 March 2025 regarding the resolution by the Company's board of directors to carry out a [...]
Silo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 as a Groundbreaking PTSD Treatment
26/03/2025
Preclinical Data to Support Advancement Toward First-in-Human Clinical Trials SARASOTA, FL, March 26, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage [...]
Bluejay Therapeutics Announces First Patient Dosed in AZURE-1 Global Pivotal Clinical Trial Evaluating Brelovitug (BJT-778) as a Monotherapy Treatment for Chronic Hepatitis D
26/03/2025
AZURE-1 will evaluate the efficacy and safety of brelovitug compared to delayed treatment REDWOOD CITY, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Bluejay Therapeutics , a clinical-stage biopharmaceutical company [...]
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on April 3
26/03/2025
Houston, TX, March 26, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) is pleased to invite investors to a webinar on April 3, 2025, at 4:15 p.m. ET. The exclusive [...]
Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry
26/03/2025
Company’s 6 th U.S. patent adds to comprehensive IP portfolio protecting its unique drug screening technology Patent protection strengthens Company’s competitive position as it prepares for planned entry into multi- [...]
Prime Biome Reviews Controversy Disclosure Report: Surprising Facts and Figures Revealed
26/03/2025
ST. PETERSBURG, Fla., March 26, 2025 (GLOBE NEWSWIRE) -- In today's fast-paced world, guts and skin health has become a crucial aspect of total wellbeing. Prime Biome Gummies have attracted a lot of attention in the [...]
Zelluna ASA [ZLNA]: Share capital increase resolution
26/03/2025
Oslo, Norway, 26 March, 2025 Reference is made to the stock exchange notice published on 9 January 2025 regarding an extraordinary general meeting held in Zelluna ASA (the " Company "), where it was resolved to carry [...]
BriaCell to Present Clinical and Preclinical Data at the 2025 AACR Conference
26/03/2025
PHILADELPHIA and VANCOUVER, British Columbia, March 26, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that [...]
MBX Biosciences to Participate in the 24th Annual Needham Virtual Healthcare Conference
26/03/2025
CARMEL, Ind., March 26, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the [...]
Aligos Therapeutics Presents Positive Data at APASL 2025
26/03/2025
SOUTH SAN FRANCISCO, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet [...]
Starton Therapeutics to Present Poster at the American Association for Cancer Research (AACR) Annual Meeting 2025
26/03/2025
PARAMUS, N.J., March 26, 2025 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary dermal [...]
Catheter Precision to Participate in and Share Data at Upcoming Industry Conferences
26/03/2025
FORT MILL, S.C., March 26, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac [...]
Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2025 American Association for Cancer Research Meeting
26/03/2025
Fort Lee, NJ, March 26, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative precision [...]

Pages